Company search
Overview
Performance
Portfolio
ESG
Dividends
Charges
Gearing
Research
Announcements
Management
Documents
Invest
Engage
Unlisted holdings
| % of total assets |
|---|
| N/R |
Please note that the percentage of unlisted holdings is displayed for companies that have reported this data to the AIC. “N/R” means the data has not been reported to the AIC. Where data is reported, it may be subject to valuation lags.
Top holdings
Data as at : 30/11/2023
| Investment | % of total assets |
|---|---|
| Option Care Health Inc | 6.9 |
| Insmed Inc | 6.9 |
| Axonics Inc | 6.9 |
| Evolent Health Inc Class A | 6.6 |
| Exact Sciences Corp | 6.4 |
| Intuitive Surgical Inc | 5.2 |
| Pacific Biosciences of California Inc | 5.1 |
| Apellis Pharmaceuticals Inc | 4.8 |
| Bio-Rad Laboratories Inc Class A | 4.8 |
| Charles River Laboratories International Inc | 4.8 |
Geographic breakdown
Data as at : 31/03/2024
| Country | % of total assets |
|---|---|
| USA | 100.0 |
Depending on the nature of the underlying asset classes, geographic breakdowns may not always add up to 100%.
Industry breakdown
Data as at : 30/11/2023
| Industry | % of total assets |
|---|---|
| Healthcare | 100.0 |
Scroll
Asset breakdown
Data as at : 30/11/2023
| Asset | % of total assets |
|---|---|
| Stock | 100.0 |
Detailed asset breakdown
Data as at : 30/11/2023
| Asset | % of total assets |
|---|---|
| North America - stock | 96.2 |
| Asia (excl Japan) - stock | 2.7 |
| Other - stock | 1.2 |
Data provided by Morningstar.
Company documents provided by FE fundinfo.
